(Thanks to Atid-EDI) Early trials of NiCord (umbilical cord stem cells) from Israel’s Gamida Cell have proved successful in maintaining the health of patients with high-risk hematological malignancies. The treatment was safe and reduced the time to recovery period.
http://www.gamida-cell.com/press_item.asp?ID=54